Department of Diagnostic Radiology, Faculty of Medicine, Yamagata University, Iida-Nishi 2-2-2, 990-9585 Yamagata, Japan.
Eur J Radiol. 2013 Jan;82(1):146-50. doi: 10.1016/j.ejrad.2012.04.040. Epub 2012 Oct 18.
Chronic progressive neuro-Behçet's disease (CPNBD) resembles multiple sclerosis (MS) on patient background and image findings, and therefore is difficult to diagnose. The purpose is to identify the characteristic magnetic resonance imaging (MRI) findings of CPNBD and to clarify the differences between the MRI findings of CPNBD and those of MS.
The subjects consist of a CPNBD group (n=4; 1 male and 3 females; mean age, 51 y.o.), a MS group (n=19; 3 males and 16 females; mean age, 45 y.o.) and a normal control group (n=23; 10 males and 13 females; mean age, 45 y.o.). Brain stem atrophy, cerebellar atrophy, and leukoencephalopathy were retrospectively evaluated in each subjects. In middle sagittal brain MR images, the prepontine distance was measured as an indirect index of brain stem and cerebellar atrophy and the pontine and mesencephalic distance was measured as a direct index of brain stem atrophy. These indexes were statistically analyzed.
Brain stem atrophy, cerebellar atrophy, and leukoencephalopathy were seen in all CPNBD cases. Prepontine distance was significantly different between the CPNBD group and the MS group (p<0.05), and between the CPNBD group and the normal control group (p<0.001). Pontine and mesencephalic distance were significantly different between the CPNBD group and the MS group (p<0.001, p<0.01 respectively), and between the CPNBD group and the normal control group (p<0.001).
Chronic progressive neuro-Behçet's disease should be considered in patients with brain stem and cerebellar atrophy in addition to leukoencephalopathy similar to that seen in multiple sclerosis.
慢性进展性神经贝赫切特病(CPNBD)在患者背景和影像表现上类似于多发性硬化症(MS),因此难以诊断。本研究旨在确定 CPNBD 的特征性磁共振成像(MRI)表现,并阐明 CPNBD 和 MS 的 MRI 表现之间的差异。
研究对象包括 CPNBD 组(n=4;1 名男性和 3 名女性;平均年龄 51 岁)、MS 组(n=19;3 名男性和 16 名女性;平均年龄 45 岁)和正常对照组(n=23;10 名男性和 13 名女性;平均年龄 45 岁)。回顾性评估每位患者的脑干萎缩、小脑萎缩和脑白质病。在正中矢状面脑 MRI 图像中,测量桥前距离作为脑干和小脑萎缩的间接指标,测量桥脑和中脑距离作为脑干萎缩的直接指标。对这些指标进行了统计学分析。
所有 CPNBD 患者均存在脑干萎缩、小脑萎缩和脑白质病。CPNBD 组与 MS 组(p<0.05)和 CPNBD 组与正常对照组(p<0.001)的桥前距离存在显著差异。CPNBD 组与 MS 组(p<0.001,p<0.01)和 CPNBD 组与正常对照组(p<0.001)的桥脑和中脑距离存在显著差异。
除了类似于多发性硬化症的脑白质病外,还应考虑到脑干和小脑萎缩的患者患有慢性进展性神经贝赫切特病。